CIMT

The 14th Annual Meeting of the Association for Cancer Immunotherapy connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT 2016 is expected to bring together 1,000 international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy. In addition, CIMT unites leading international experts through working groups on immune monitoring, drug development policies, and the translation of scientific knowledge into drug development.

For 2016, the CIMT program committee is preparing plenary sessions from pre-clinical research to clinical devlopment on the topics of therapeutic vaccination, cellular therapy, improving immunity, tumor microenvironment, antibodies, regulatory research and immunoguiding. The plenary sessions will be complemented by a poster exhibit and selected poster short talk sessions, as well as a business workshop on the translation and commercialization of cancer immunotherapies and diagnostics.

• Top of the News & Events